| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Age-related increase of pulse pressure and gene polymorphisms in essential hypertension: a preliminary study
|
Mourad, Jean-Jacques
|
|
2002
|
3 |
2 |
p. 109-115
|
artikel
|
| 2 |
Comparison of the effects of antihypertensive treatment with angiotensin II blockade and beta-blockade on carotid wall structure and haemodynamics: protocol and baseline demographics
|
Ariff, Ben
|
|
2002
|
3 |
2 |
p. 116-122
|
artikel
|
| 3 |
Grossly elevated serum angiotensin-converting enzyme activities are still suppressible with ACE inhibitor therapy
|
Witham, Miles D
|
|
2002
|
3 |
2 |
p. 138-138
|
artikel
|
| 4 |
High plasma adrenomedullin concentrations in patients with high-renin essential hypertension
|
Letizia, Claudio
|
|
2002
|
3 |
2 |
p. 126-129
|
artikel
|
| 5 |
Lack of rapid aldosterone effects on forearm resistance vasculature in health
|
Gunaruwan, Prasad
|
|
2002
|
3 |
2 |
p. 123-125
|
artikel
|
| 6 |
Nephrectomy and peritoneal dialysis eliminates circulating renin and controls uraemia in the rat
|
Pedersen, Trine Fischer
|
|
2002
|
3 |
2 |
p. 130-134
|
artikel
|
| 7 |
Renal graft failure after addition of an angiotensin II receptor antagonist to an angiotensin-converting enzyme inhibitor: unmasking of an unknown iliac artery stenosis
|
Kamper, Anne-Lise
|
|
2002
|
3 |
2 |
p. 135-137
|
artikel
|
| 8 |
Review: Calcium channel blockade in combination with angiotensin-converting enzyme inhibition or angiotensin II (AT1-receptor) antagonism in hypertensive diabetics and patients with renal disease and hypertension
|
Swales, Philip
|
|
2002
|
3 |
2 |
p. 79-89
|
artikel
|
| 9 |
Review: Combining renin-angiotensin-aldosterone system blockade with diuretic therapy for treatment of hypertension
|
Motwani, Joseph G
|
|
2002
|
3 |
2 |
p. 72-78
|
artikel
|
| 10 |
Review: Rationale for combination therapy in the treatment of hypertension
|
Sica, Domenic A
|
|
2002
|
3 |
2 |
p. 63-65
|
artikel
|
| 11 |
Review: Renin-angiotensin system antagonism and lipid-lowering therapy in cardiovascular risk management
|
Chiong, Jun R
|
|
2002
|
3 |
2 |
p. 96-102
|
artikel
|
| 12 |
Review: The frequent need for three or more drugs to treat essential hypertension. What evidence for optimal combinations?
|
Swift, Pauline A
|
|
2002
|
3 |
2 |
p. 103-108
|
artikel
|
| 13 |
Review: The practical aspects of combination therapy with angiotensin receptor blockers and angiotensin-converting enzyme inhibitors
|
Sica, Domenic A
|
|
2002
|
3 |
2 |
p. 66-71
|
artikel
|
| 14 |
Review: Vasopeptidase inhibitors
|
Sagnella, Giuseppe A
|
|
2002
|
3 |
2 |
p. 90-95
|
artikel
|
| 15 |
The SCOPE Trial
|
Sever, Peter
|
|
2002
|
3 |
2 |
p. 61-62
|
artikel
|
Tijdschrift beschrijving